Monthly Archives - September 2017

Siamab Therapeutics Presented New Data for its Anti-STn Antibody Therapeutics Showing Myeloid-Derived Suppressor Cells as a Promising Cancer Immunotherapy Target at Cambridge Healthtech Institute’s Targeting Tumor Myeloid Cells Conference

Siamab Therapeutics, Inc., a biopharmaceutical company developing novel cancer immunotherapies, today announced it presented new preclinical data for its novel anti-Sialyl-Tn (STn) antibodies and antibody drug conjugates (ADCs) targeting myeloid-derived suppressor cells (MDSCs) at Cambridge Healthtech Institute’s Inaugural Targeting Tumor Myeloid Cells Conference, held September 27-28, 2017 in Boston. Read more >>

Bible Hill woman hopes to raise funds for a device that can enhance her vision

Most of us take such things for granted – reading print at a comfortable distance, identifying which car is yours in the parking lot or comprehending what another person is doing just across the room.
For Tammy Martin, the ability to perform such feats stirs a sense of awe.
Tammy was born with optic nerve hypoplasia, a condition where the optic nerves are underdeveloped. She has poor depth perception and everything appears very small, as if she were a considerable distance […]

Turning over a new leaf

Ingredients obtained by KnipBio from specialised strains of leaf symbiont bacteria have been demonstrated to offer promising alternatives to fishmeal in aquafeeds, following a number of recent trials. Read more >>

Corbus Pharmaceuticals Announces Presentation of Six Abstracts and New Anabasum Data at 2017 ACR Annual Meeting

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a clinical stage drug development company targeting rare, chronic, serious inflammatory and fibrotic diseases, announced today that its abstracts have been selected for presentations at the American College of Rheumatology (“ACR”) 2017 Annual Meeting being held November 3-8, 2017 in San Diego, California. Read more >>

VisionCorps offers visually impaired chance to try eSight & NuEyes electronic smart glasses

On Oct. 5, VisionCorps is inviting the public to come try electronic smart glasses designed to help those with severe visual impairments see better.
The VisionCorps Foundation purchased one eSight and three NuEyes units to use for demonstrations and studying their impact on workers at the VisionCorps manufacturing, food processing and administrative businesses. Read more >>

Eyewear Industry Moving towards Building Smart Glasses Equipped with Sensors

For instance, eSight has developed the electronic glasses that can help people with limited vision who cannot see with ordinary glasses or lenses. The glasses developed by eSight transmits images from the camera to a small internal screen. These images are transferred in such a way that it beams the video into the person’s peripheral vision. Read more >>